TARS

#1394

Tarsus Pharmaceuticals, Inc. Common Stock

75.5200

+1.46%

Сектор:

Базовая:

Валюта прибыли:

Дневной диапазон

Годовой диапазон

Дневное изменение

+1.46%

Месячное изменение

+11.06%

6-месячное изменение

+14.32%

Годовое изменение

+14.32%

Предыдущее закрытие

74.4350

Open

75.5200

Bid

Ask

Low

75.5200

High

75.5200

Объем

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 21.14 M3.75 M49.03 M117.49 M83.03 M12.45 M 12.45 M Cash from investing activities 456 K586 K144.63 M140.6 M199.19 M42.12 M 42.12 M Cash from financing activities 131.77 M21 K93.99 M130.18 M154.66 M143.39 M 143.39 M Free cash flow 20.68 M3.16 M48.52 M111.99 M76.46 M2.59 M 2.59 M

TARS

Financials

Новости

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.

ASML, With Unique AI Tech, Leads 8 Hot Growth Stocks Joining IBD's Top Screens

Construction Star Leads 11 Hot Stocks To Various Best Growth Lists like IBD 50, Sector Leaders

AMD, IBM among market cap stock movers on Tuesday

Tarsus: доходы оказались ниже прогнозов, прибыльa обогнал ожидания в Q4

Tarsus earnings missed by $0.12, revenue topped estimates

Tarsus Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-02-23

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates

Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth

Tarsus готовится к отчету на фоне роста выручки и сокращения убытков

Tarsus faces earnings test as losses narrow, revenue surges